Oct 19, 2011 09:00 EDT “Global customer proximity is Attana’s next step towards assuring that our customers receive highest quality support and service through established distributors,” commented Teodor Aastrup, CEO and founder of Attana.
Press Release
Biosensor- Attana Cell 200, label free, real time kinetics on cells
Feb 01, 2010 02:37 EST
Attana AB introduces the Attana Cell 200 – the first system to permit real-time kinetic analysis of molecular interactions directly on cell surfaces, bringing drug development a step closer to the body.
As the first company in the world, Attana launches a system measuring molecular interactions label free directly on cell surfaces. In line with Attana’s innovative strategy, the Attana Cell 200 is a revolutionary system that rapidly generates biologically relevant information on molecular interactions with cell surfaces. Thanks to groundbreaking innovations and sedulous developments, Attana is the only player on the market that offers cells integrated as sensor surface. The experiments mimic real life conditions and generate information with higher biological relevance in comparison with traditional synthetic sensor surfaces.
Drug development is financially risky and time consuming. To save money and time the industry needs to early identify and eliminate unsuitable candidates. Attana Cell 200 biosensor system improves the selection process by rapidly identifying promising drug candidates. This enables early and well informed decisions in selecting relevant candidates while reducing unnecessary development costs and saving time. The Attana Cell 200 is label free, can run unpurified candidate molecules and has high throughput, resulting in fast and efficient screening of many drug candidates.
Attana Cell 200 is launched with new applications such as kinetic evaluation of cellular biomolecular interactions, e.g. antibody-receptor and lectin-carbohydrate, competition assays and cell capturing.
For more information, please contact Gabriela Suhoschi, Marketing Manager, Attana AB: gabriela.suhoschi@attana.com, +46 (0) 8- 674 57 12 or visit our web:www.attana.com
For press release in Swedish please see attached document.
About Attana AB
Based in Stockholm, Sweden, Attana AB develops and sells biosensors for analysis of biomolecular interactions. Our systems have since 2003 been employed at leading life science companies and universities worldwide, working in a wide variety of research fields. Attana’s biosensors can be used to determine specificity, kinetics and affinity, amongst other binding characteristics of biomolecules and macrostructures of varying species such as cells, antibodies, proteins, viruses and bacteria.
Attached Files
Categorization
- Tags:
- biosensor,
- label free,
- real time,
- kinetic on cells,
- attana cell 200,
- attana,
- qcm
Related press releases
Mar 03, 2011 03:38 EST March 3rd, 2011, Stockholm, Sweden – Attana AB, developer of biosensors, is proud to announce our participation in Today in America with Terry Bradshaw in their series on topics, trends, and issues related to “Improving Diagnostic Outcomes through Biosensor Technology” as part of the show’s “Medical Minutes” series.
Related news
The combination between biochemical and cell based assay- Attana appears in International Trade News
Mar 02, 2012 09:15 EST Long before pharmaceutical substances are tried on animals or human beings, they are carefully tested in simulated environments. Attana's biosensors characterize molecular interactions exactly as they would occur in the human body, the company offers its clients relevant information before further tests are carried out.
Nov 16, 2011 09:32 EST One efficient tool in the selection process is biochemical label‐free kinetic characterisation of interactions between candidate and target molecules. Information on association and dissociation rates and affinity is provided under purified conditions. However, the results obtained are often different compared to the affinity results obtained with cell based methods.
Nov 02, 2011 10:15 EDT "Swedish Life Science is a comprehensive introduction to an industry that employs some 40,000 people in Sweden, accounts for 20 per cent of Swedish net export worth over over SEK 40 billion, and is fast becoming a cornerstone of the national economy."
May 31, 2011 10:00 EDT Find out latest news, events and collaborations from Tecan- read the interview with Attana's Sales and Marketing Manager, Gabriela Suhoschi about Attana's collaboration with Tecan's on page 5!
May 23, 2011 09:00 EDT We are pleased to have met so many like minded members of industry during the Protein Engineering Summit 2011 in Boston last week. If you were there but didn't get the chance to taste our exquisite espresso you are always welcome to stop by our booth during our upcoming events!
Dec 21, 2010 05:51 EST Attana appears in Dresdner Neueste Nachrichten, a regional German newspaper in association with the inauguration of the new “B CUBE” research labs of the Technische Universität Dresden. The new research labs are part of a large regional German investment for scientific research and innovative technologies. The Attana 200 appears here as one of B CUBE’s innovative biosensor technologies
Jul 05, 2010 09:49 EDT When we founded Attana in 2002, we had a dream of creating a tool that could mimic reality. We were set to do this by developing an instrument capable of measuring biological interactions exactly as the actual events in the human body.
Jun 02, 2010 10:06 EDT We are happy to have met so many industry people during the Protein Engineering Summit 2010 in Boston last week, and if you were there but didn't get the chance to taste our exquisite espresso you are welcome to stop by our booth during our upcoming events!
Mar 23, 2010 04:00 EDT
Nov 12, 2009 15:19 EST When we founded Attana in 2002, we had a dream of creating a tool that could mimic reality. We were set to do this by developing an instrument capable of measuring biological interactions exactly as the actual events in the human body.
Related blog posts
Dec 01, 2010 10:07 EST Recently a film crew visited the Attana office to prepare our participation on Terry Bradshaw’s “Today in America” show. Their research team had heard about our ground breaking cell based biosensor and asked us to participate on the show. The days before the filming were filled with intense preparation, and consequently on the day of shooting everything went smoothly..
Jul 05, 2010 10:17 EDT We consider it strategically important to keep collaborating with our customers, university researchers in particular, to stay on top and keep getting inspired.
Jun 01, 2010 10:17 EDT Ernst & Young recently released their 24th annual report Beyond borders: global biotechnology report 2010, presenting, among other things, five guiding principles for biotech companies working in the new economy where funding is scarce and customers careful:
Related events
Feb 25, 2010 03:52 EST On Tuesday morning on the 23rd of March, Dr. Miriam Dwek , Senior Lecturer in Biochemistry, Department of Molecular & Applied Biosciences, University of Westminster will present a case study on Revealing Real Time Cell Surface Interaction Analysis: A focus on lectine- cell Glycan Interactions. The exclusive Discovery Summit 2010 presents a unique opportunity to examine the challenges an...
Time: Feb 23 18:00 EST
Location:
Majestic Barrière Hotel | Cannes | France
http://www.discovery-summit.com/
Feb 22, 2010 03:29 EST Attana's CEO, Dr. Teodor Aastrup will be presenting at BIT’s 2nd Annual International Congress of Antibodies-2010 on the subject of scientific basis and emerging technologies for antibodies. Dr. Aastrup's will present molecular characterization in crude samples and on complex targets such as whole cells, using the Attana quartz crystal microbalance technology. http://www.bitlifesciences....
Time: Mar 23 - Mar 25
Location:
Beijing, China- Continental Grand Hotel (Beijing International Convention Center)
May 04, 2010 09:42 EDT Label-free kinetics on cells, Analysis of molecules in crude samples, Phage and yeast display of antibodies - are just a few of the topics that Attana will touch upon during the PEG summit 2010! Attana's will present drug conjugate data about the Attana Cell 200 – the first system to permit real-time kinetic analysis of molecular interactions directly on cell surfaces, bringing drug developm...
Time: May 04 - May 20
Location:
Sheraton Hotel in Boston
Massachusetts
USA
Feb 26, 2010 13:19 EST Staffan Grenklo Ph.D, Cell Biologist, Attana AB Presentation focus: In today’s quest for new therapeutic drugs, it is increasingly important to obtain early and informative data on potential agents in order to save time and costs. Combining biosensor technologies contributing to detailed information on molecular interactions with an experimental approach, as close as possible to the natural ...
Time: May 16 - May 20
Location:
Sheraton Boston Hotel, Boston Massachusetts
May 10, 2010 03:00 EDT KTH-Royal Institute of Technology, Sweden will present a poster using Attana technology! Poster Session 1 – Wednesday, 26 May 2001 Photo-click immobilization of carbohydrates on polymeric surfaces - A quick method to functionalize surfaces for biomolecular recognition studies. Authors: Oscar Norberg, L Deng, M Yan, O Ramström, KTH-Royal Institute of Technology, Sweden, Portland State ...
Time: May 25 - May 27
Location:
Scottish Conference & Exhibition Centre (SECC)
Glasgow, UK
Dec 22, 2010 05:08 EST Attana will be at the PepTalk 2011 conference in San Diego. The conference takes place during 10-14 January at the legendary Hotel Del Coronado, and will be a full week with speeches, buzz sessions, short courses, exhibitions and much more, all related to protein science.
Time: Jan 09 - Jan 14
Location:
Hotel Del Coronado, San Diego, USA
Feb 18, 2011 04:06 EST Join our panel discussion- Wed 23rd @ 16.40 Biologically relevant information- improving success of clinical trials! Panelists: Dr Teodor Aastrup, CEO, Attana Dr Juan Carlos Almagro, Research Fellow, Head, Antibody Design Unit, Centocor Dr Jesus Zurdo, Head of Innovation LCM Development Services, Lonza Dr Alain Beck, Head of Physico Chemistry, Centre d'Immunologie Pierre Fabre ...
Time: Feb 21 - Feb 24
Location:
InterCity Hotel, Frankfurt
Mar 07, 2011 03:00 EST Attana will be participating at the International Congress of Antibodies in Beijing and present on several topics: "In Vitro Evolution of Allergy Vaccine Candidates with Reduced IgE-Binding and T-Cell Activation Capacity" - Ola B Nilsson and the Karolinska Institute "Kinetics on Cells - Bridging the Gap Between Traditional Biosensors and Cell-Based Assays" - Samuel Altun, Cell Application...
Time: Mar 22 - Mar 25
Location:
Beijing, China
Mar 15, 2011 04:00 EDT Tecan US Inc. our local partner in North America, will present Attana's biosensors during this five-day event with more than 2,000 scientists, innovators, researchers and industry analysts from around the globe.
Time: Mar 27 - Mar 31
Location:
Orlando, Florida, US
Apr 20, 2011 03:00 EDT Discover what really happens at the cell surface - Attend the Attana Kinetics on Cells course! • A biosensor - Reveals full kinetics • Cell based assays - Disclose the entire cell surface environment • The Attana kinetics on cells course - Demonstrates the value of combining them! Bridging the gap between biosensors and cell based assays! When: 26-27 October 2011 Price: 15...
Time: Oct 25 - Oct 27
Location:
Stockholm, Sweden
Oct 26, 2011 09:41 EDT Professor Zhichao Pei, College of Science, Northwest A&F University, China will give a presentation on: ”Real time cell surface interaction analysis: a focus on lectin-cell glycan." BIT Life Sciences is dedicated to supporting the pharmaceutical professionals and bioscientists to exchange ideas, network, seeking partnership overseas, pinpoint and identify opportunities and global drug R & D...
Time: Nov 03 - Nov 06
Location:
Shenzhen Convention and Exhibit Center, China
Apr 04, 2012 09:05 EDT "A novel tool for characterization of molecular interactions on cell surfaces"- presentation by Teodor Aastrup, Attana CEO.
Time: Jun 25 - Jun 27
Location:
Santa Marina Hotel, Mykonos, Greece
Related images
Apr 07, 2010 09:01 EDT The Attana Cell 200 enables kinetic characterization of interactions on intact cells, in real time. Cells can be cultivated directly on Attana’s proprietary cell surface or captured from cell suspension before analysis.
Jun 02, 2010 09:18 EDT Cell and biochemical assays Analyte/ligand types: - Adherent cells - Suspension cells - Fixed and non-fixed cells - Crude samples - Proteins, antibodies, carbohydrates - Viruses, bacteria Applications: - Kinetics on cells - Cell capturing - Detailed kinetics - Concentration determination - Competition assay - Epitope mapping - Off-rate selection - Aggregation characterization
Jun 02, 2010 09:14 EDT The Attana Cell 200 enables kinetic characterization of interactions on intact cells, in real time. Cells can be cultivated directly on Attana’s proprietary cell surface or captured from cell suspension before analysis.
Related videos
Mar 02, 2011 03:00 EST
Attana is featured in Today in America with Terry Bradshaw in their series on topics, trends, and issues related to “Improving Diagnostic Outcomes through Biosensor Technology” as part of the show’s “Medical Minutes” series. In the clip we find out why biological relevance is important and how it is possible to shorten the time between research initiation and new drug on the market.
Length 5:00
Related documents
Mar 06, 2012 09:05 EST Single-walled carbon have properties that make them useful for drug delivery, and their photo-thermal effects make them potentially useful in a wide range of applications, particularly the treatment of solid tumors. Follow link for full abstract: www.attana.com/pub_cells. See abstract on video (Attana Cell 200 data shown in min 04:55) http://www.dovepress.com/articles.php?article_id=9317
May 24, 2011 09:00 EDT Attana Cell 200- Bridging the gap between traditional biosensors and cell based assays! Drug development is costly and risky, the need for technologies that accelerate the process of drug discovery becomes more urgent. This paper shows four instances of how the Attana Cell 200 biosensor provides data that enhances the ability to select the right drug candidates earlier in the process.
Apr 07, 2011 04:17 EDT Attana has several Quartz Crystal Microbalance (QCM) based instruments and applications, all catering to crucial needs and developed in close collaboration with industry and universities. Examples include kinetic analysis on cell surfaces, candidate selection screening, aggregation characterization, epitope mapping and concentration determination of biopharmaceuticals.
Jun 04, 2010 09:16 EDT A list of publications where the Attana systems have been utilized. The publications relate to various species such as glycovesicles, antibodies, proteins, nanobodies and more.
Jun 09, 2010 10:03 EDT The objective of this application note was to determine the glycosylation profile of cancer cells using a cell based QCM Biosensor assay. Among other things, it was found that a single surface can be used to perform lectin screening and to provide a highly relevant and reproducible determination of the glyco-profile of cancer cells.
Jun 16, 2010 10:40 EDT The objective of this application note was to evaluate newly developed therapeutic antibodies in a biologically relevant context (cells) in order to detect failing candidates at an earlier stage. Among other things, it was found that real-time screening of drug candidates in a synthetic and in a cellular context together provides highly informative and biologically relevant data.
Jun 23, 2010 10:54 EDT The objective of this application note was to determine the binding properties of the lectin ConA towards human epidermoid carcinoma cells. Among other things it was found that a kinetic approach may be used to determine the apparent affinity and rate constants of lectin-cell glycan interactions, providing a greater understanding of the mechanism involved in the lectin recognition of cancer cells.
Jul 14, 2010 10:19 EDT The objective of this application note was to determine off-rates of antibodies in mouse hybridoma supernatants and scaffold proteins in bacterial lysates using the Attana 200 system and Low Non-specific Binding (LNB) surfaces. Among other things, a method that can be used for clone selection, vaccine screening, biomarker discovery, biomanufacturing and performance studies was developed.














Add commentThe comment was saved
Prior to publication, it must be approved by Attana AB.